期刊文献+

二硫键稳定的抗CD3/抗CD19微型双功能抗体的表达及活性测定 被引量:1

Construction and Expression of Disulphide Stabilized AntiCD3/AntiCD19 Diabody
原文传递
导出
摘要 构建了抗CD3/抗CD19(Diabody)微型双功能抗体,并且为增强其稳定性进一步改造为二硫键稳定的抗CD3/抗CD19(ds-Diabody)微型双功能抗体,表达并纯化后测定其生物学活性。构建二硫键稳定的抗CD3/抗CD19表达载体p AYZds CD3CD19,转化感受态大肠杆菌16C9进行原核表达,分离纯化后,经12%SDS-PAGE及Westen-blot鉴定。应用间接免疫荧光和竞争性免疫荧光结合流式细胞分析技术(FACS)检测ds-Diabody与CD19+Raji细胞和CD3+Jurkat细胞的结合活性。改造后的ds-Diabody能够在原核表达系统中进行可溶性表达,ds-Diabody在非还原性SDS-PAGE中,在45 k处可见一条带,Westen-blot在同一位置显示有带,在还原性SDSPAGE中45 k处条带消失,在28 k和26 k各有一条带,Western-blot在28 k显示有带,这些均与理论相符,45 k为二硫键稳定的二聚体,在还原剂巯基乙醇作用下二硫键断开,形成28 k和26 k的2条带。FACS检测ds-Diabody可与CD19+Raji细胞和CD3+Jurkat细胞特异结合,并能竞争性抑制单抗HIT3a和HIT19a与上述细胞的结合。说明改造后的二硫键稳定的抗CD3/抗CD19双功能抗体既能在原核系统中进行可溶性表达,同时又保留了与细胞的结合活性。 A diabody is a promising immunotherapy which is capable of recruiting a polyclonal T cells to specific antibody targetedexpressing tumor cells. However,the heavy chain( VH) and the light chain( VL) domains of diabodies dissociate easily because they are associated non-covalently. So,it is necessary to remodel the diabody to increase its stability in order to enhance the antitumor activity. Cysteine residues were introduced into the V domains of the anti CD3 segment of the anti CD3 / anti CD19 diabody by recombinant gene engineering technology to generate its disulfide stabilized( ds) format. Diabody and ds-diabody were both expressed in E. coli strain 16C9 and purified by 6 × His-tag affinity chromatography. And then,they were analyzed by Coomassie brilliant blue staining and western blot. The binding activity of the two diabodies was analyzed by flow cytometry. The Ser-100 of anti CD3 VLand Gly-44 of anti CD3 VHof diabody were successfully replaced by cysteines to generate the ds diabody. They were both produced and purified from E. coli 16C9 cells with excellent yields ranging from 4 to 5 mg / L of culture medium. Under reducing conditions,the ds diabody resolved and detected as two bands of approximately 28 ku and 26 ku,consistent with those of the diabody. However,under non-reducing conditions,the ds diabody was detected as one band at approximately 40 ku. Western blot analysis using an anti-His tag antibody proved that the two sc Fvs were linked by the disulfide bond. The ds diabody bound to both CD3-positive Jurkat cells and CD19-positive Raji cells as efficiently as the parental diabody. It was successful to construct the expression vector of ds-anti CD3 /anti CD19 diabody,and the soluble ds-diabody was purified with high yield and high affinity to target cells.
出处 《药物生物技术》 CAS 2014年第5期389-392,共4页 Pharmaceutical Biotechnology
关键词 DIABODY 抗CD3 抗CD19 二硫键 药物稳定性 Diabody,Anti-CD3,Anti-CD19,Disulphide bond,Drug stability
  • 相关文献

参考文献8

  • 1李崴,范冬梅,程昕,师锐赞,刘荣,任思楣,王敏,杨铭.抗CD3/抗CD19微型双功能抗体的构建、表达及活性测定[J].中国癌症杂志,2010,20(4):241-246. 被引量:6
  • 2王金宏,刘娟妮,纪庆,高瀛岱,熊冬生,杨纯正.抗CD3 ScFv/抗PgP ScFv双功能抗体的高密度发酵与纯化[J].药物生物技术,2008,15(4):249-252. 被引量:1
  • 3高瀛岱,熊冬生,许元富,彭晖,邵晓枫,杨纯正,朱祯平.抗CD3/抗Pgp微型双功能抗体的构建和表达[J].生物工程学报,2003,19(4):444-449. 被引量:18
  • 4Panagiotis Tsirigotis,Theofanis Economopoulos.Monoclonal antibodies in the treatment of lymphoid malignancies[J].Journal of Steroid Biochemistry and Molecular Biology.2007(3)
  • 5Dan Lu,Xenia Jimenez,Haifan Zhang,Amanda Atkins,Laura Brennan,Paul Balderes,Peter Bohlen,Larry Witte,Zhenping Zhu.Di-diabody: a novel tetravalent bispecific antibody molecule by design[J].Journal of Immunological Methods.2003(1)
  • 6.Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics 1 1 Edited by J. Karn[J].Journal of Molecular Biology.1999(1)
  • 7Margitta Alt,Rolf Müller,Roland E Kontermann.Novel tetravalent and bispecific IgG-like antibody molecules combining single-chain diabodies with the immunoglobulin γ1 Fc or CH3 region[J].FEBS Letters.1999(1)
  • 8Tapan K Bera,Masanori Onda,Ulrich Brinkmann,Ira Pastan.A bivalent disulfide-stabilized fv with improved antigen binding to erbb2 1 1 Edited by I. Wilson[J].Journal of Molecular Biology.1998(3)

二级参考文献25

  • 1栾凤君,杨纯正.一株人红白血病多药耐药细胞系(K562/A02)的建立及其耐药特性...[J].中华肿瘤杂志,1993,15(2):101-103. 被引量:68
  • 2陈森,饶青,王建祥,王敏.抗人CD19单链抗体基因的构建、表达及功能测定[J].生物工程学报,2005,21(5):686-691. 被引量:12
  • 3邵晓枫,熊冬生,高灜岱,许元富,郭红星,刘芳,郭桂庆,杨纯正.抗抗CD3 ScFv单克隆抗体的制备及鉴定[J].中国免疫学杂志,2007,23(2):142-145. 被引量:7
  • 4SHEN D C YANG X F YANG C Yet al.Generation and characirization of monoclonal antibody againstHIT3a[J].Acta Academiae Medicinac Sinicac (中国医学科学院学报),199,15:157-162.
  • 5XIONG D S YANG C Z SHAO X Fet al.Generation and characterization of monoclonal antibodiesagainst P-glycoprolein(Pgp)[J]. Chin J HemoZo/( 中国血液学杂志),1999,20(6):326-327.
  • 6XUYF XIONGDS YANG C Z.The mutation of anti-CD3 antibody(H1T3a)gene and its ex-pression[J].Chin Jhematol(中国血液学杂志),2001,22(5):252-255.
  • 7Joly P, Lallemand A, OumHamed Z. Effects of verapamil and S9788 on MDR-lmRNA expression studied by in situ hy bridlzation[J]. Antlcancer Res, 1996,16: 3609.
  • 8Murron J R, Durivage H J, Buzaid A C, etal. Trifluopera zine as a modulator of multidrug resistance in refractory breast cancer [J]. Cancer Chemother Pharmacol, 1996, 38.-65.
  • 9Y Gao, D Xiong, M Yang, et al. Efficient inhibition of mul- tidrug-reslstant human tumors with a recombinant bispecific anti-P-glycoproteln x anti-CD3 diabody [J]. Leukemia, 2004, 18(3) ,513.
  • 10Lee S Y. High cell density culture of Escherichia coli[J]. Trends Biotechnol, 1996, 4(3) : 98.

共引文献22

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部